Sanofi Indias standalone net profit jumped 31% Rs 91.3 crore in Q4 FY25 as compared with Rs 69.7 crore in Q4 FY24. Revenue increased 9.7% YoY to Rs 514.9 crore in Q4 FY25.
The expected additional revenue will be around Rs 3,877.50 crore. The US Food and Drug Administration (US FDA) has issued a ...
In today’s stock market trade, a slew of stocks will be on investors’ radar, including Tata Power, Life Insurance Corporation ...
16hon MSN
HYDERABAD: In a major setback to Hyderabad-based pharma player Granules India Ltd, the US Food and Drug Administration (USFDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results